LINTHICUM, Md., July 13, 2006 (PRIMEZONE) -- Dialysis Corporation of America (Nasdaq:DCAI) announced the certification and opening of its new dialysis facility in York, Pennsylvania which, as previously announced, began construction in the latter part of 2005.
President & CEO Stephen Everett commented, "We have completed the construction of our York, Pennsylvania facility, passed all required inspections, and have opened the facility for patient care. This center is our first in the York County area and our ninth in the state of Pennsylvania. With our affiliation with physicians from Nephrology Associates of York, a prominent and well respected medical practice in this area, we are confident that this center will be extremely successful from both clinical and financial standards."
The new facility offers state-of-the-art equipment and technology, has been designed with patient comfort in mind, and includes 24 treatment stations, along with a Peritoneal Suite for patients opting for that modality.
Dialysis Corporation of America currently owns or manages 31 free-standing operating kidney hemodialysis centers in Georgia, Maryland, New Jersey, Ohio, Pennsylvania, South Carolina and Virginia providing patients with a full range of quality in-center and at-home dialysis services, as well as providing in-hospital services. The company has three new centers under development in Georgia and South Carolina.
This release contains forward-looking statements that are subject to risks and uncertainties that could affect the business and prospects of the company and cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to, maintaining continued growth and profitability, delays beyond the company's control with respect to future business events, the highly competitive environment in the establishment and operation of dialysis centers, the ability to develop or acquire additional dialysis facilities, whether patient bases of the company's dialysis facilities can mature to provide profitability, the extensive regulation of dialysis operations, government rate determination for Medicare reimbursement, pricing pressure from private payors, and other risks detailed in the company's filings with the SEC, particularly as described in the company's annual report on Form 10-K for the fiscal year ended December 31, 2005. The historical results contained in this press release are not necessarily indicative of future performance of the company.
The company's press releases, corporate profile, corporate governance materials, quarterly and current reports, and other filings with the SEC are available on Dialysis Corporation of America's internet home page: http://www.dialysiscorporation.com.